Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
出版年份 2021 全文链接
标题
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
作者
关键词
Cancer management, Drug resistance, Tumor suppressor genes, Loss of function, Functional restoration of TSGs
出版物
DRUG RESISTANCE UPDATES
Volume -, Issue -, Pages 100770
出版商
Elsevier BV
发表日期
2021-06-18
DOI
10.1016/j.drup.2021.100770
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
- (2021) Jing-Quan Wang et al. DRUG RESISTANCE UPDATES
- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin
- (2021) Tobias Wijshake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapeutic strategies to overcome taxane resistance in cancer
- (2021) Tuyelee Das et al. DRUG RESISTANCE UPDATES
- Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
- (2021) Rajiv Pathak et al. ACTA NEUROPATHOLOGICA
- ZBTB28 induces autophagy by regulation of FIP200 and Bcl-XL facilitating cervical cancer cell apoptosis
- (2021) Li Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer epigenetics: Past, present and future
- (2021) Jae Eun Lee et al. SEMINARS IN CANCER BIOLOGY
- Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application
- (2021) Guanghui Ren et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Recent insight into the role of FBXW7 as a tumor suppressor
- (2020) Kanae Yumimoto et al. SEMINARS IN CANCER BIOLOGY
- Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
- (2020) Erin Flynt et al. Cells
- MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer
- (2020) Arnaud Augert et al. CANCER CELL
- p27 as a transcriptional regulator: New roles in development and cancer
- (2020) Seyedeh Fatemeh Razavipour et al. CANCER RESEARCH
- Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
- (2020) Wenxiao Jiang et al. DRUG RESISTANCE UPDATES
- Nanomedicine to target multidrug resistant tumors
- (2020) Elise Lepeltier et al. DRUG RESISTANCE UPDATES
- RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy
- (2020) Ziyou Lin et al. EMBO JOURNAL
- Inhibition of Importin β1 Augments the Anticancer Effect of Agonistic Anti-Death Receptor 5 Antibody in TRAIL-resistant Tumor Cells
- (2020) Yuko Kojima et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response
- (2020) Olga Pernía et al. Cancers
- Targeting nuclear import and export in hematological malignancies
- (2020) Boaz Nachmias et al. LEUKEMIA
- Targeting p53 for the treatment of cancer
- (2020) Michael J. Duffy et al. SEMINARS IN CANCER BIOLOGY
- EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells
- (2020) Xingyue Zong et al. CANCER RESEARCH
- New insights into the activities and toxicities of the old anticancer drug doxorubicin
- (2020) Sabina Y. van der Zanden et al. FEBS Journal
- Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas
- (2020) Laura Esteban-Burgos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation
- (2020) Frederick Guzman et al. Cancers
- EDIL3 promotes epithelial–mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells
- (2020) J. Gasca et al. Cell Death Discovery
- Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy
- (2020) Mi Jeong Kim et al. CANCER BIOLOGY & THERAPY
- Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
- (2020) Hongmei Cui et al. CURRENT MEDICINAL CHEMISTRY
- Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
- (2020) Bowen Li et al. DRUG RESISTANCE UPDATES
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer
- (2020) Luciana Petti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FRMD6 has tumor suppressor functions in prostate cancer
- (2020) Jakob Haldrup et al. ONCOGENE
- The Tumor Suppressor PALB2: Inside Out
- (2019) Mandy Ducy et al. TRENDS IN BIOCHEMICAL SCIENCES
- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial‐mesenchymal transition and inducing apoptosis
- (2019) Ya‐Nan Xue et al. PROSTATE
- The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination
- (2019) Weixing Zhao et al. Annual Review of Biochemistry
- Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells
- (2019) Yaru Sheng et al. CELL PROLIFERATION
- Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
- (2019) Salih Demir et al. HAEMATOLOGICA
- Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy
- (2019) Elisa Lozano et al. HEPATOLOGY
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer
- (2019) Yuhong Sun et al. Cell Death & Disease
- ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
- (2019) Yichong Ning et al. Cell Death & Disease
- Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
- (2019) Baojie Zhang et al. Cancers
- Application of PD-1 Blockade in Cancer Immunotherapy
- (2019) Xiaomo Wu et al. Computational and Structural Biotechnology Journal
- Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer
- (2019) Changlei Xi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibitors of nuclear transport
- (2019) David A Jans et al. CURRENT OPINION IN CELL BIOLOGY
- Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Zefei Jiang et al. LANCET ONCOLOGY
- Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil
- (2019) Tong Liu et al. NEOPLASIA
- DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors
- (2019) Yaqin Shi et al. NEOPLASIA
- Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
- (2019) Mohammed I. Y. Elmallah et al. Cancers
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- PML hyposumoylation is responsible for the resistance of pancreatic cancer
- (2019) Mirna Swayden et al. FASEB JOURNAL
- The SUMO Pathway in Hematomalignancies and Their Response to Therapies
- (2019) Mathias Boulanger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
- (2019) Yan-ping Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein
- (2019) Hidetsugu Kawai et al. NEOPLASIA
- p21 in Cancer Research
- (2019) Shamloo et al. Cancers
- PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
- (2019) Cretella et al. Cancers
- N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor
- (2019) Donatella Fiore et al. Cancers
- Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS)
- (2019) Jiang Du et al. PATHOLOGY & ONCOLOGY RESEARCH
- YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
- (2019) Yulin Shi et al. Nature Communications
- The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene
- (2019) Jesse L. Berry et al. Genes
- ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness
- (2019) Qingyu Luo et al. CELL DEATH AND DIFFERENTIATION
- Towards the overcoming of anticancer drug resistance mediated by p53 mutations
- (2019) Xin Cao et al. DRUG RESISTANCE UPDATES
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties
- (2019) Jiahui Si et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management
- (2019) Santosh Shenoy Cancer Management and Research
- The Roles of Sirtuin Family Proteins in Cancer Progression
- (2019) Erhu Zhao et al. Cancers
- Mechanisms of Resistance to PD-1 and PD-L1 Blockade
- (2018) Theodore S. Nowicki et al. CANCER JOURNAL
- ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
- (2018) Qingyu Luo et al. CANCER LETTERS
- The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by IncreasingNOTCH1Expression and Targeting Tumor-Initiating Cells
- (2018) Sarmishtha De et al. CANCER RESEARCH
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- Genome dimensions control biological and toxicological functions; myth or reality?
- (2018) Diane C. Wang et al. CELL BIOLOGY AND TOXICOLOGY
- How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
- (2018) Thorsten Stiewe et al. DRUG RESISTANCE UPDATES
- Multiple functions of m6A RNA methylation in cancer
- (2018) Yutian Pan et al. Journal of Hematology & Oncology
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells
- (2018) Kristen E Clements et al. NUCLEIC ACIDS RESEARCH
- Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas
- (2018) Natalia Saenz-Ponce et al. Science Translational Medicine
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
- (2018) Gabriela Nestal de Moraes et al. Oncogenesis
- The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms
- (2018) Reyhaneh Moradi Marjaneh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
- (2018) Mohammad Askandar Iqbal et al. MOLECULAR ASPECTS OF MEDICINE
- Sorafenib: key lessons from over 10 years of experience
- (2018) Bernard Escudier et al. Expert Review of Anticancer Therapy
- Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression
- (2018) Xin Jin et al. MOLECULAR CELL
- The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
- (2017) Renier Vélez-Cruz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
- (2017) Dae Ho Lee PHARMACOLOGY & THERAPEUTICS
- Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells
- (2016) Mei-ling Han et al. ACTA PHARMACOLOGICA SINICA
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1
- (2016) Ramin Dubey et al. CANCER RESEARCH
- Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer
- (2016) Ufuk Mert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process
- (2016) Evan K Day et al. CURRENT OPINION IN BIOTECHNOLOGY
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
- (2016) Hsin-An Chen et al. HEPATOLOGY
- Targeting the Nuclear Import Receptor Kpn 1 as an Anticancer Therapeutic
- (2016) P. J. van der Watt et al. MOLECULAR CANCER THERAPEUTICS
- Immunological off-target effects of imatinib
- (2016) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non‐Small Cell Lung Cancer and the Role of Biopsy at Progression
- (2016) Mark A. Socinski et al. ONCOLOGIST
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Importins and exportins as therapeutic targets in cancer
- (2016) Amit Mahipal et al. PHARMACOLOGY & THERAPEUTICS
- Targeting tumor suppressor genes for cancer therapy
- (2015) Yunhua Liu et al. BIOESSAYS
- DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers
- (2015) Y.-C. Lin et al. CLINICAL CANCER RESEARCH
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
- (2015) M N Washington et al. Cell Death & Disease
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Therapeutic targeting of tumor suppressor genes
- (2014) Luc G. T. Morris et al. CANCER
- BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability
- (2014) Kienan I. Savage et al. FEBS Journal
- Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
- (2014) Yoshihito Yokoyama et al. Journal of Gynecologic Oncology
- Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
- (2014) Tongsen Zheng et al. Molecular Cancer
- Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents
- (2014) Joel G. Turner et al. SEMINARS IN CANCER BIOLOGY
- Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
- (2014) Guang-Xia Chen et al. OncoTargets and Therapy
- Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
- (2013) C. J. Walker et al. BLOOD
- Transcriptional Regulation and Its Misregulation in Disease
- (2013) Tong Ihn Lee et al. CELL
- CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
- (2013) Sina Gogolin et al. CELL CYCLE
- BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling
- (2013) M Sung et al. ONCOGENE
- BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas
- (2013) T R Burton et al. Cell Death & Disease
- Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells
- (2012) Vicky Goler-Baron et al. BIOCHEMICAL PHARMACOLOGY
- Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance
- (2012) Takenori Ogawa et al. CELL CYCLE
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- Translational approaches targeting the p53 pathway for anti-cancer therapy
- (2011) Frank Essmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- Belinostat: clinical applications in solid tumors and lymphoma
- (2011) L Rhoda Molife et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells
- (2011) Yuko Kojima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- (2011) M Michaelis et al. Cell Death & Disease
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8
- (2010) Satoshi Kurita et al. CANCER SCIENCE
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- The regulation of protein phosphorylation
- (2009) Louise N. Johnson BIOCHEMICAL SOCIETY TRANSACTIONS
- Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells
- (2009) Takeshi Hori et al. CANCER LETTERS
- Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Gliomas
- (2009) A. Elias et al. CLINICAL CANCER RESEARCH
- p53-Induced Apoptosis and Inhibitors of p53
- (2009) Surendra Nayak et al. CURRENT MEDICINAL CHEMISTRY
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
- (2009) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization
- (2008) G. Wei Xu et al. APOPTOSIS
- Imatinib resistance in CML
- (2008) Gisella Volpe et al. CANCER LETTERS
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More